ClearSight Therapeutics
<UNKNOWN> · 2 known investors
ClearSight Therapeutics develops over-the-counter ophthalmic eye care products to treat dry eye, contact lens discomfort, and ocular surface infections using its proprietary CS-001 lubrication platform. The company operates within FDA OTC monograph pathways to address large, underserved consumer eye care needs.
BiotechHealthtechMedical Devices